GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | Birc5 | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | CTD | Bortezomib results in decreased expression of BIRC5 mRNA; Bortezomib results in decreased expression of BIRC5 protein | PMID:17898295 PMID:18850583 PMID:19636294 PMID:20977926 | Birc5 | increases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | CTD | Bortezomib results in increased expression of BIRC5 protein | PMID:17510429 | Birc5 | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | CTD | [Irinotecan co-treated with Bortezomib] results in decreased expression of BIRC5 protein; [romidepsin co-treated with Bortezomib] results in increased cleavage of BIRC5 protein; Bortezomib promotes the reaction [capillarisin results in decreased expression of BIRC5 protein] | PMID:16373703 PMID:18223231 PMID:24333736 | |
Go Back to source page | Continue to Ontology report |